Insights

These were the best performing ASX 200 shares last week

It certainly was a great week for these ASX 200 shares.
The post These were the best performing ASX 200 shares last week appeared first on The Motley Fool Australia. –

The S&P/ASX 200 Index (ASX: XJO) continued its impressive run and pushed higher again last week. The benchmark index added 0.2% or 16.9 points to end the period at 7,312.3 points.

While a good number of shares pushed higher with the market, some climbed more than most. Here’s why these were the best performers on the ASX 200 last week:

Altium Limited (ASX: ALU)

The Altium share price was the best performer on the ASX 200 last week with a massive 28.6% gain. Investors were scrambling to buy the electronic design software provider’s shares after it announced the receipt of a takeover approach from US software giant Autodesk. It made a formal, non-binding, indicative and unsolicited proposal of $38.50 per share to acquire the company, which represented a 41.5% premium to its last close price. However, it was also a 4.2% discount to its 52-week high. The Altium Board believed it undervalued the company and rejected the proposal.

Iress Ltd (ASX: IRE)

The Iress share price wasn’t far behind with a 20.4% gain over the five days. Investors were buying the financial technology company’s shares amid speculation that it could be a takeover target as well. However, Iress shot down the rumours, confirming that it has not received any direct approach.

Whitehaven Coal Ltd (ASX: WHC)

The Whitehaven Coal share price was on form and charged 19% higher last week. This appears to have been driven by a broker note out of Ord Minnett on Tuesday. That note reveals that its analysts have upgraded the coal miner’s shares to a buy rating with a $3.00 price target. It made the move on the belief that its shares had been oversold and also due to the rising thermal coal price.

Mesoblast limited (ASX: MSB)

The Mesoblast share price was a strong performer and jumped 16.2% over the five days. This was despite there being no news out of the biotechnology company. Though, this could have been driven by a delayed reaction to a broker note out of Bell Potter from a week earlier. Its analysts put a buy (spec) rating and $3.60 price target on the company’s shares after looking through its remestemcel-L in COVID related acute respiratory distress syndrome (ARDS) trial results.

The post These were the best performing ASX 200 shares last week appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of May 24th 2021

More reading

These were the worst performing ASX 200 shares last week

The Mesoblast (ASX:MSB) share price has rocketed 18% this week
What moved the Stockland (ASX:SGP) share price this week?
These 3 shares were the biggest gainers of the ASX 200 this week

Here are the 3 most traded ASX 200 shares today

James Mickleboro does not own any shares mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Altium. The Motley Fool Australia owns shares of and has recommended Altium. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!